✦ LIBER ✦

The development of monocyclic pyrazolone based cytokine synthesis inhibitors

✍ Scribed by Adam Golebiowski; Jennifer A. Townes; Matthew J. Laufersweiler; Todd A. Brugel; Michael P. Clark; Cynthia M. Clark; Jane F. Djung; Steven K. Laughlin; Mark P. Sabat; Roger G. Bookland; John C. VanRens; Biswanath De; Lily C. Hsieh; Michael J. Janusz; Richard L. Walter; Mark E. Webster; Marlene J. Mekel

Book ID: 108073608
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 191 KB
Volume: 15
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2005.03.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Development of New Bicyclic Pyrazole

The Development of New Bicyclic Pyrazole-Based Cytokine Synthesis Inhibitors.

✍ Jennifer A. Townes; et al. et al. 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 170 KB

Synthesis of acyl derivatives of pyrazol

Synthesis of acyl derivatives of pyrazolone inducing the formation of antiviral inhibitors

✍ A. S. Saratikov; E. V. Shmidt; V. E. Yavorovskaya; M. A. Luttseva; T. P. Prishch 📂 Article 📅 1978 🏛 Springer 🌐 English ⚖ 412 KB

Development of the next generation of HI

Development of the next generation of HIV-1 integrase inhibitors: Pyrazolone as a novel inhibitor scaffold

✍ Victor Hadi; Yung-Hyo Koh; Tino Wilson Sanchez; Danielle Barrios; Nouri Neamati; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 522 KB

HIV-1 integrase (IN), one of the essential enzymes in HIV infection, has been validated as a target for HIV treatment. While more than 20 drugs have been approved by the FDA to treat HIV/AIDS, only one drug, Raltegravir (1), was approved as an IN inhibitor. The rapid mutation of the virus, which lea

ChemInform Abstract: Design and Synthesi

ChemInform Abstract: Design and Synthesis of Monocyclic β-Lactams as Mechanism-Based Inhibitors of Human Cytomegalovirus Protease.

✍ A. D. BORTHWICK; G. WEINGARTEN; T. M. HALEY; M. TOMASZEWSKI; W. WANG; Z. HU; J. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 33 KB 👁 1 views

Design and Synthesis of Monocyclic β-Lactams as Mechanism-Based Inhibitors of Human Cytomegalovirus Protease. -Starting from monocyclic β-lactams novel human cytomegalovirus protease inhibitors, e.g. (III), (VII),and (VIII), are developed. The most potent one among them is the derivative (VII) with

ChemInform Abstract: Development of the

ChemInform Abstract: Development of the Next Generation of HIV-1 Integrase Inhibitors: Pyrazolone as a Novel Inhibitor Scaffold.

✍ Victor Hadi; Yung-Hyo Koh; Tino Wilson Sanchez; Danielle Barrios; Nouri Neamati; 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 23 KB 👁 2 views

The Development of Novel Inhibitors of T

The Development of Novel Inhibitors of Tumor Necrosis Factor-α (TNF-α) Production Based on Substituted [5,5]-Bicyclic Pyrazolones.

✍ Matthew J. Laufersweiler; et al. et al. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 26 KB 👁 1 views

## Abstract For Abstract see ChemInform Abstract in Full Text.